AURA
Income statement / Annual
Last year (2023), Aura Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Aura Biosciences, Inc.'s net income was -$76.41 M.
See Aura Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$1.30 M |
$1.18 M |
$835,000.00 |
$831,000.00 |
$509,000.00 |
Gross Profit |
-$1.30 M |
-$1.18 M |
-$835,000.00 |
-$831,000.00 |
-$509,000.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$63.94 M
|
$42.24 M
|
$25.16 M
|
$18.04 M
|
$19.62 M
|
General & Administrative
Expenses |
$19.76 M
|
$18.06 M
|
$10.09 M
|
$4.16 M
|
$4.52 M
|
Selling & Marketing
Expenses |
$19.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$19.76 M
|
$18.06 M
|
$10.09 M
|
$4.16 M
|
$4.52 M
|
Other Expenses |
$0.00 |
-$5,000.00 |
-$11,000.00 |
$3,000.00 |
-$44,000.00 |
Operating Expenses |
$83.70 M |
$60.30 M |
$35.25 M |
$22.21 M |
$24.14 M |
Cost And Expenses |
$84.99 M |
$60.30 M |
$35.25 M |
$22.21 M |
$24.14 M |
Interest Income |
$0.00 |
$1.86 M |
$13,000.00 |
$3.00 |
$5.00 |
Interest Expense |
$0.00 |
-$850,000.00 |
$13,000.00 |
$3,000.00 |
$5,000.00 |
Depreciation &
Amortization |
$1.30 M
|
$1.18 M
|
$835,000.00
|
$831,000.00
|
$509,000.00
|
EBITDA |
-$83.70 M
|
-$59.97 M
|
-$35.24 M
|
-$21.38 M
|
-$23.63 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$8.72 M
|
$1.53 M
|
-$1,000.00
|
$3,000.00
|
-$60,000.00
|
Income Before Tax |
-$76.27 M |
-$58.76 M |
-$35.25 M |
-$22.21 M |
-$24.20 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$137,000.00 |
-$1.53 M |
-$830,000.00 |
$3,000.00 |
$5,000.00 |
Net Income |
-$76.41 M |
-$57.23 M |
-$34.42 M |
-$22.21 M |
-$24.21 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-1.93 |
-1.91 |
-1.18 |
-0.76 |
-0.83 |
EPS Diluted |
-1.93 |
-1.91 |
-1.18 |
-0.76 |
-0.83 |
Weighted Average Shares
Out |
$39.62 M
|
$29.94 M
|
$29.21 M
|
$29.22 M
|
$29.22 M
|
Weighted Average Shares
Out Diluted |
$39.62 M
|
$29.94 M
|
$29.21 M
|
$29.22 M
|
$29.22 M
|
Link |
|
|
|
|
|